Author:
Body-Malapel M.,Djouina M.,Waxin C.,Langlois A.,Gower-Rousseau C.,Zerbib P.,Schmidt A.-M.,Desreumaux P.,Boulanger E.,Vignal C.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference55 articles.
1. Kaplan, G. G. & Ng, S. C. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152, 313–321.e2 (2017).
2. Souza, H. S. Pde & Fiocchi, C. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13–27 (2016).
3. Bamias, G., Pizarro, T. T. & Cominelli, F. Pathway-based approaches to the treatment of inflammatory bowel disease. Transl. Res. J. Lab. Clin. Med. 167, 104–115 (2016).
4. Targownik, L. E. et al. Temporal trends in initiation of therapy with tumor necrosis factor antagonists for patients with inflammatory bowel disease: a population-based analysis. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 15, 1061–1070.e1 (2017).
5. Colombel, J.-F., Narula, N. & Peyrin-Biroulet, L. Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology 152, 351–361.e5 (2017).
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献